Nachrichten zur Viking Therapeutics Aktie

Viking Therapeutics: Full-Speed Ahead

…

Viking Therapeutics stock soars on plans for Phase 3 obesity drug trial By Investing.com

Viking Therapeutics stock soars on plans for Phase 3 obesity drug trial…

VKTX Posts Wider-Than-Expected Loss in Q4, Stock Up on Pipeline Updates

Viking Therapeutics posts a wider-than-expected Q4 loss, but shares jump as it advances oral VK2735 into late-stage obesity studies.…

Viking Therapeutics: The Under?the?Radar GLP?1 Contender Growth Hunters Cant Ignore

This stock has been known to soar after good news.…

Heres Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market

Viking Therapeutics, Inc. (VKTX) concluded the recent trading session at $29.06, signifying a -3.9% move from its prior days close.…

Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts

Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $32.22, moving 5.49% from the previous trading session.…

Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts

Viking Therapeutics, Inc. (VKTX) closed at $34.09 in the latest trading session, marking a +2.13% move from the prior day.…

Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Viking Therapeutics, Inc. (VKTX) reached $31.86 at the closing of the latest trading day, reflecting a -7.21% change compared to…

Viking Therapeutics, Inc. (VKTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

…

Appetite for weight-loss deals broader than visible, Viking CEO says

Weight-loss drug developer Viking Therapeutics CEO said on Monday that strategic interest in weight-loss drug deals is broader than it…

Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know

Viking Therapeutics, Inc. (VKTX) reached $31.99 at the closing of the latest trading day, reflecting a +1.07% change compared to…

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $32.12, denoting a -9.32% move from…

How A Wall Street Analyst Started A $4 Billion Obesity Drug Company

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1…

Viking Therapeutics: The Obesity Drugs Gold Rush Is Far From Over

…

Viking Therapeutics: A Wide-Open Oral GLP-1 Market

…

Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $35.32, marking a -3.13% move from the previous day.…

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $36.41, marking a +2.85% move from the previous day.…

Viking Therapeutics, Inc. (VKTX) Registers a Bigger Fall Than the Market: Important Facts to Note

Viking Therapeutics, Inc. (VKTX) closed at $36.15 in the latest trading session, marking a -2.51% move from the prior day.…

Viking Therapeutics: Prepping For A Critical 2026

…

Viking Therapeutics (VKTX) Up 1% Since Last Earnings Report: Can It Continue?

Viking Therapeutics (VKTX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Viking Therapeutics, Inc. (VKTX) Presents at Jefferies London Healthcare Conference 2025 Transcript

…

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?

One major biotech investor just walked away from Viking Therapeutics. Here’s what the move may—and may not—mean for the company’s…

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Streets Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly…

Viking Therapeutics Aktie: Biotech-Geheimtipp im Adipositasmarkt - Kursziel steigt auf 107 USD

Vancouver (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von Canaccord Genuity:Die Analysten von Canaccord Genuity belassen die Einstufung für die Aktie von Viking…

Viking Therapeutics: Canaccord sieht 194 % Kurspotenzial mit Verweis auf die potenziellen Medikamente gegen Adipositas

Viking Therapeutics (VKTX) ist ein biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Entwicklung neuartiger Therapien für Stoffwechsel- und…

Viking Therapeutics Aktienanalyse: Neues Kursziel 75 USD - JPMorgan bleibt bullish

Bad Marienberg (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse: JPMorgan bleibt optimistisch trotz Kurszielsenkung auf 75 USDStarkes Signal von JPMorganDie Analysten von JPMorgan…

Viking Therapeutics: The Prime Target In The Obesity Gold Rush

…

Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $33.54, denoting a -3.44% move from…

Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? @themotleyfool #stocks $LLY $GS $NVO $VKTX

These stocks have climbed in the triple digits over the past few years.…

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $32.37, indicating a +2.65% shift from the previous…

Viking Therapeutics: A Speculative Buy

…

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $27.88, denoting a +1.86% move from…

Viking Therapeutics: Overdue For Gains

…

Viking Therapeutics: A Huge Reward Or A Total Loss

…

Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $25.09, indicating a -5.78% shift from the previous…

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

Based on the average brokerage recommendation (ABR), Viking Therapeutics (VKTX) should be added to ones portfolio. Wall Street analysts overly…

Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $24.97, denoting a -4.88% move from…

Viking Therapeutics, Inc. (VKTX) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript

…

Viking Therapeutics: Oral Study Disappoints, Competitor Gets Bought Out (Rating Downgrade)

…

Viking Therapeutics, Inc. (VKTX) Q4 2023 Earnings Call Transcript

…

Viking Therapeutics, Inc. (VKTX) Q2 2025 Earnings Call Transcript

…

Viking Therapeutics Posts Wider Q2 Loss

Key Points- Loss per share was $(0.58), falling short of analyst expectations by $(0.13), or 29.1% (GAAP, Q2 2025).- Research…

Viking (VKTX) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATEWednesday, July 23, 2025 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Brian LianChief Financial Officer…

Viking Therapeutics shares fall as Q2 loss exceeds estimates By Investing.com

Viking Therapeutics shares fall as Q2 loss exceeds estimates…

3 Monster Stocks in the Making to Buy Right Now

Key PointsCRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential remaining.Viking Therapeutics is targeting…

Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $32.07, representing a +1.39% change from its previous close.…

The Best Stocks to Invest $1,000 In Right Now

Key PointsThese stocks offer exposure to three different industries and add to the diversification of your portfolio.You can bet on…

Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts

Viking Therapeutics, Inc. (VKTX) reached $31.29 at the closing of the latest trading day, reflecting a +2.93% change compared to…

Better Growth Buy: Eli Lilly vs. Viking Therapeutics

Key PointsEli Lilly is a leader in the weight loss drug market, generating blockbuster revenue.Viking Therapeutics recently launched a phase…

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Key PointsWall Streets smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all downside…